Guardion Health Sciences, Inc. (GHSI)
After hours:
| Previous close | 8.50 |
| Open | 8.72 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 8.50 - 8.72 |
| 52-week range | 5.01 - 10.75 |
| Volume | |
| Avg. volume | 13,693 |
| Market cap | 10.928M |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 70.92 |
| EPS (TTM) | 0.12 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 40.00 |
GlobeNewswireGuardion Health Sciences Announces
-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at the Upcoming Special Meeting of Stockholders on May 23, 2024 Board of Directors Urges Stockholders to Vote to Approve the Sale of the Company’s Viactiv Brand and Business and Plan of Liquidation and Dissolution If both proposals are approved, stockholders would receive one or more liquidating cash distrib
Simply Wall St.Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
While Guardion Health Sciences, Inc. ( NASDAQ:GHSI ) might not have the largest market cap around , it saw a...
- GlobeNewswire
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals
